Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCitigroup Inc Regulatory News (13PH)

  • There is currently no data for 13PH

Form 8.3 - offeree

15 Apr 2021 15:22

RNS Number : 6399V
Citigroup Inc
15 April 2021
Β 

Ap19

Β 

Β 

FORMΒ 8.3

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 8.3Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANEL ACT,Β 1997,Β TAKEOVERΒ RULES,Β 2013

Β 

DEALINGSΒ BYΒ PERSONSΒ WITHΒ INTERESTSΒ INΒ RELEVANTΒ SECURITIESΒ REPRESENTINGΒ 1%Β ORΒ MORE

Β 

1. KEYΒ INFORMATION

Β 

Name of person dealing (Note 1)

Β Citigroup Inc.

Company dealt in

Willis Towers Watson plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

Β 14 April 2021

Β 

2. INTERESTSΒ ANDΒ SHORTΒ POSITIONS

Β 

(a) InterestsΒ andΒ shortΒ positionsΒ (followingΒ dealing)Β inΒ theΒ classΒ ofΒ relevantΒ securityΒ dealtΒ inΒ (NoteΒ 3)

Β 

Long

Short

Β 

Number

Β 

(%)

Number

Β 

(%)

(1) Relevant securities

3,235,142 2.51%

1,646,225 1.28%

(2) Derivatives (other than options)

25,662 0.02%

36,368 0.03%

(3) Options and agreements to purchase/sell

Β 

Β 

Total

3,260,804 2.53%

1,682,593 1.30%

Β Β Β Β Β Β Β 

Β 

(b) InterestsΒ andΒ shortΒ positionsΒ inΒ relevantΒ securitiesΒ ofΒ theΒ company,Β otherΒ thanΒ theΒ classΒ dealtΒ inΒ (NoteΒ 3)

Class of relevant security:

Long

Short

Β 

Number

Β 

(%)

Number

Β 

(%)

(1) Relevant securities

Β 

Β 

Β 

(2) Derivatives (other than options)

Β 

Β 

Β 

(3) Options and agreements to purchase/sell

Β 

Β 

Total

Β 

Β 

Β Β Β Β Β Β Β 

Β 

Ap20

Β 

Β 

1. DEALINGSΒ (NoteΒ 4)

Β 

(a) PurchasesΒ andΒ sales

Β 

Β 

Purchase/sale

Β 

Number of relevant securities

Β 

Price per unit (USD)

Purchase

2,945

Highest 242.35 Lowest 235.35

Sale

2,785

Highest 241.61 Lowest 236.72

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

Β 

Β 

Β 

Β 

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

Β 

(i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii) Exercising

Β 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

Β 

Β 

Β 

(d) OtherΒ dealingsΒ (includingΒ transactionsΒ inΒ respectΒ ofΒ newΒ securities)Β (NoteΒ 4)

Β 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Β 

Β 

Β 

Β 

Ap21

Β 

2. OTHERΒ INFORMATION

Β 

Agreements,Β arrangementsΒ orΒ understandingsΒ relatingΒ toΒ optionsΒ orΒ derivatives

Β 

Β 

Β 

Β 

FullΒ detailsΒ ofΒ anyΒ agreement,Β arrangementΒ orΒ understandingΒ betweenΒ theΒ personΒ disclosing andΒ anyΒ otherΒ personΒ relatingΒ toΒ theΒ votingΒ rightsΒ ofΒ anyΒ relevantΒ securitiesΒ underΒ anyΒ option referredΒ toΒ onΒ thisΒ formΒ orΒ relatingΒ toΒ theΒ votingΒ rightsΒ orΒ futureΒ acquisitionΒ orΒ disposalΒ ofΒ anyΒ relevantΒ securitiesΒ toΒ whichΒ anyΒ derivativeΒ referredΒ toΒ onΒ thisΒ formΒ isΒ referenced.Β IfΒ none,Β this shouldΒ beΒ stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

IsΒ aΒ SupplementalΒ FormΒ 8Β attached?Β (NoteΒ 9) Β NO

Β 

Date of disclosure

15 April 2021

Contact name

Damian Flanagan

Telephone number

+ 44 (0) 2890409676

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETUVUSRAUUSAAR
Date   Source Headline
21st Apr 20214:25 pmRNSForm 8.3 - offeree
20th Apr 20213:43 pmRNSForm 8.3 - offeree
19th Apr 20214:58 pmRNSForm 8.3 - offeree
16th Apr 20214:40 pmRNSForm 8.3 - offeree
15th Apr 20213:22 pmRNSForm 8.3 - offeree
14th Apr 20213:38 pmRNSForm 8.3 - offeree
13th Apr 20211:37 pmRNSForm 8.3 - offeree
12th Apr 20213:45 pmRNSForm 8.3 - offeree
9th Apr 20213:19 pmRNSForm 8.3 - offeree
8th Apr 20213:46 pmRNSForm 8.3 - offeree
7th Apr 20213:58 pmRNSForm 8.3 - offeree
6th Apr 20213:33 pmRNSForm 8.3 - offeree
6th Apr 20219:40 amRNSForm 8.3 - offeree
1st Apr 20214:40 pmRNSForm 8.3 - offeree
31st Mar 20213:56 pmRNSForm 8.3 - offeree
30th Mar 20215:13 pmRNSForm 8.3 - [offeree]
29th Mar 20212:47 pmRNSForm 8.3 - [offeree]
29th Mar 20217:00 amRNSForm 8.3 - [offeror]
26th Mar 20215:19 pmRNSForm 8.3 - [Offeror]
30th Apr 202012:25 pmRNSArticle 8
27th Apr 202010:09 amRNSDelisting of Notes Series EMTN6619

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.